Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Adjuvant chemotherapy regimen for the three patients

From: Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?

  Patient number 1 Patient number 2 Patient number 3
First-line (adjuvant) chemotherapy GEMOX (6 cycles) FOLFOX (6 cycles) GEMZAR (8 cycles)
Second-line chemotherapy FOLFOX (8 cycles) / /
Third-line chemotherapy FOLFIRI (6 cycles) / /